What is Roche?
Roche is a pharmaceuticals and diagnostics company company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.
- Category
- Pharmaceuticals and diagnostics company
- Headquarters
- Basel, Switzerland
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; SIX: ROG
What is Roche?
Roche is a pharmaceuticals and diagnostics company company headquartered in Basel, Switzerland. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Roche is a pharmaceuticals and diagnostics company company headquartered in Basel, Switzerland. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Roche should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Roche offer?
Roche's profile centers on Oncology medicines, Diagnostics, Genentech, Clinical pipeline.
- Oncology medicines· Pharmaceuticals and diagnostics company
- Diagnostics· Pharmaceuticals and diagnostics company
- Genentech· Pharmaceuticals and diagnostics company
- Clinical pipeline· Pharmaceuticals and diagnostics company
- Personalized healthcare· Pharmaceuticals and diagnostics company
- Lab diagnostics· Pharmaceuticals and diagnostics company
How does Roche make money?
Roche makes money through commercial activity tied to pharmaceuticals and diagnostics company.
Roche monetizes through the model common to pharmaceuticals and diagnostics company: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Roche?
Roche's named executives should be verified on the official leadership or investor-relations page before outreach.
- Roche executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Roche finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Roche operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Roche's leadership?
Roche should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.roche.comHow is Roche funded?
Roche's current status is Public company; SIX: ROG.
Roche's capital profile is best understood through its current public-company status: Public company; SIX: ROG. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Roche get here?
Roche's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingRoche is foundedThe company begins building in pharmaceuticals and diagnostics company.
- Scale-upCommercial footprint expandsRoche broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; SIX: ROGPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Roche's competitors?
Roche competes with larger incumbents and focused specialists in pharmaceuticals and diagnostics company.
Roche — frequently asked questions
